Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

By afschroeder • February 12, 2026

Ibrahim M, Tariq S, Afridi MK, Zafar A, Khamisani FA, Aminpoor H, Arfin SMW, Fonarow GC, Greene SJ, Musani MH, Waqas SA. Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost. 2026 Jan-Dec;32:10760296261422490. doi: 10.1177/10760296261422490. Epub 2026 Feb 11. PMID: 41671172.

Tags: acute coronary syndrome, Cardiology/Epi, dual antiplatelet therapy, meta-analysis, P2Y12 inhibitor, percutaneous coronary intervention, Publications

Effect of colchicine on progression of known coronary atherosclerosis in patients with stable coronary artery disease: EKSTROM randomized placebo controlled trial

Budoff MJ, Bhandari M, Iskander B, Ghanem AK, Kinninger A, Stark J, Garikapati V, Chilukuri S, Hankil V, Krishnan S, Punnanithinont N, Ichikawa K, Kambalapalli[...]

Hemodynamics-driven magnetoelastic vascular grafts for stenosis diagnosis

Chen G, Chung T, Liu Z, Li YR, Scott K, Zhao X, Carol J, Park S, Zhou Y, Kim WJ, Ge X, Colby GP, Li[...]

Editorial: The newer paradigms in hypertension research and management

Marwaha K, Norris K, Mody FV. Editorial: The newer paradigms in hypertension research and management. Front Med (Lausanne). 2026 Jan 23;13:1781466. doi: 10.3389/fmed.2026.1781466. PMID: 41658579;[...]